Engineered cross-reacting nanobodies simplify comparative oncology between humans and dogs.
Sign Up to like & getrecommendations! Published in 2018 at "Veterinary and comparative oncology"
DOI: 10.1111/vco.12359
Abstract: Antibodies cross-reacting with homologue antigens in different species would be essential reagents for the development of comparative oncology studies. In comparison with conventional immunoglobulin Gs, recombinant nanobodies (single-domain variable regions of heavy-chain only antibodies of… read more here.
Keywords: nanobodies simplify; comparative oncology; oncology; cross reacting ... See more keywords